Tegafur/gimeracil/oteracil‐induced eosinophilic pneumonia

Toshiyuki Sumi; Hisashi Nakata; Yuji Mori; Hiroki Takahashi

doi:10.1002/rcr2.551

Respirology Case Reports (May 2020)

Tegafur/gimeracil/oteracil‐induced eosinophilic pneumonia

Toshiyuki Sumi,
Hisashi Nakata,
Yuji Mori,
Hiroki Takahashi

Affiliations

Toshiyuki Sumi: Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan
Hisashi Nakata: Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan
Yuji Mori: Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan
Hiroki Takahashi: Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan

DOI: https://doi.org/10.1002/rcr2.551
Journal volume & issue: Vol. 8, no. 4
pp. n/a – n/a

Abstract

Read online

Key message Clinicians should be aware that eosinophilic pneumonia is one of the types of drug‐induced lung injury that can be caused by tegafur/gimeracil/oteracil (TS‐1).

Published in Respirology Case Reports

ISSN: 2051-3380 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/20513380

About the journal

Abstract

Keywords